Aflatoxins B 1, B 2 and G 1 modulate cytokine secretion and cell surface marker expression in J774A.1 murine macrophages

Toxicology in Vitro

Volumn 26, Issue 5, 2012, Pages 686-693

  Bruneau, Johanna C ^a   Stack, Edwina ^a,b   O'Kennedy, Richard ^a,b   Loscher, Christine E ^a  

^a DUBLIN CITY UNIVERSITY   (Ireland)

^b DUBLIN CITY UNIVERSITY   (Ireland)

Author keywords

Aflatoxins; Immunomodulation; Immunosuppression; Inflammation; J774A.1; Macrophage

Indexed keywords

AFLATOXIN B1; AFLATOXIN B2; AFLATOXIN G1; CD14 ANTIGEN; CELL SURFACE MARKER; INTERLEUKIN 10; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CELL ASSAY; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY TEST; DOWN REGULATION; IMMUNOMODULATION; MACROPHAGE ACTIVATION; NONHUMAN; PROTEIN EXPRESSION; TOXIN ANALYSIS; UPREGULATION;

AFLATOXINS; ANIMALS; ANTIGENS, CD14; CARCINOGENS; CELL LINE; CELL SURVIVAL; CYTOKINES; IMMUNOSUPPRESSIVE AGENTS; MACROPHAGES; MICE; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

BACTERIA (MICROORGANISMS); MURINAE; NEGIBACTERIA;

EID: 84861531149     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2012.03.003     Document Type: Article

References (28)

1. Akira S., Uematsu S., Takeuchi O. Pathogen recognition and innate immunity. Cell 2006, 124:783-801.
2. Creppy E.E. Update of survey, regulation and toxic effects of mycotoxins in Europe. Toxicol. Lett. 2002, 127:19-28.
3. Cusumano V., Rossano F., Merendino R.A., Arena A., Costa G.B., Mancuso G., Baroni A., Losi E. Immunobiological activities of mould products: functional impairment of human monocytes exposed to aflatoxin B1. Res. Microbiol. 1996, 147:385-391.
4. Devegowda G., Murthy T.N.K. Mycotoxins: their effects in poultry and some practical solutions. The Mycotoxin Blue Book 2005, 25-56. Nottingham University Press, Nottingham, UK. D.E. Diaz (Ed.).
5. Dugyala R.R., Sharma R.P. The effect of aflatoxin B1 on cytokine mRNA and corresponding protein levels in peritoneal macrophages and splenic lymphocytes. Int. J. Immunopharmacol. 1996, 18:599-608.
6. Ferrante M.C., Raso G.M., Bilancione M., Esposito E., Iacono A., Meli R. Differential modification of inflammatory enzymes in J774A.1 macrophages by ochratoxin A alone or in combination with lipopolysaccharide. Toxicol. Lett. 2008, 181:40-46.
7. Hinton D.M., Myers M.J., Raybourne R.A., Francke-Carroll S., Sotomayor R.E., Shaddock J., Warbritton A., Chou M.W. Immunotoxicity of aflatoxin B1 in rats: effects on lymphocytes and the inflammatory response in a chronic intermittent dosing study. Toxicol. Sci. 2003, 73:362-377.
8. IARC, 2002. Aflatoxin. In: IARC Monograph Evaluation of Carcinogenic Risk to Humans. Some Traditional Herbal Medicines, Some Mycotoxins, Naphthalene and Styrene, IARC, Lyon, pp. 171-300.
9. Kew M.C. Synergistic interaction between aflatoxin B1 and hepatitis B virus in hepatocarcinogenesis. Liver Int. 2003, 23:405-409.
10. Kihara T., Matsuo T., Sakamoto M., Yasuda Y., Yamamoto Y., Tanimura T. Effects of prenatal aflatoxin B1 exposure on behaviours of rat offspring. Toxicol. Sci. 2000, 53:392-399.
11. Liu B., Yu F., Chan M., Yang Y. The effects of mycotoxins, fumonisin B1 and aflatoxin B1, on primary swine alveolar macrophages. Toxicol. Appl. Pharmacol. 2002, 180:197-204.
12. McInnes I.B., Schett G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat. Rev. Immunol. 2007, 7:429-442.
13. Minervini F., Fornelli F., Lucivero G., Romano C., Visconti A. T-2 toxin immunotoxicity on human B and T lymphoid cell lines. Toxicology 2005, 210:81-91.
14. Moon E.Y., Rhee D.K., Pyo S. In vitro suppressive effect of aflatoxin B1 on murine peritoneal macrophage functions. Toxicology 1999, 133:171-179.
15. 1. Cancer Lett. 1999, 136:167-176.
16. Moon E.Y., Rhee D.K., Pyo S. Inhibition of various functions in murine peritoneal macrophages by aflatoxin B1 exposure in vivo. Int. J. Immunopharmacol. 1999, 21:47-58.
17. Moon E., Pyo S. Aflatoxin B1 inhibits CD14-mediated nitric oxide production in murine peritoneal macrophages. Int. J. Immunopharmacol. 2000, 22:237-246.
18. Mosser D.M., Edwards J.P. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 2008, 8:958-969.
19. Palsson-McDermott E.M., O'Neill L.A. Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4. Immunology 2004, 113:153-162.
20. Peraica M., Radic B., Lucic A., Pavlovic M. Toxic effects of mycotoxins in humans. Bull. World Health Organ. 1999, 77:754-766.
21. Pestka J.J., Zhou H.R., Moon Y., Chung Y.J. Cellular and molecular mechanisms for immune modulation by deoxynivalenol and other trichothecenes: unraveling a paradox. Toxicol. Lett. 2004, 153:61-73.
22. Pitt J.I. Toxigenic fungi and mycotoxins. Br. Med. Bull. 2000, 56:184-192.
23. Rossano F., Ortega De Luna L., Buommino E., Cusumano V., Losi E., Catania M.R. Secondary metabolites of Aspergillus exert immunobiological effects on human monocytes. Res. Microbiol. 1999, 150:13-19.
24. Smith J.E., Solomons G., Lewis C., Anderson J.G. Role of mycotoxins in human and animal nutrition and health. Nat. Toxins 1995, 3:187-192. discussion 221.
25. Speijers G.J.A., Speijers M.H.M. Combined toxic effects of mycotoxins. Toxicol. Lett. 2004, 153:91-98.
26. Trinchieri G., Sher A. Cooperation of Toll-like receptor in innate immune defence. Nat. Rev. Immunol. 2007, 7:179-190.
27. Ubagai T., Tansho S., Ito T., Ono Y. Influences of aflatoxin B1 on reactive oxygen species generation and chemotaxis of human polymorphonuclear leukocytes. Toxicol. in Vitro 2008, 22:1115-1120.
28. Williams J.H., Phillips T.D., Jolly P.E., Stiles J.K., Jolly C.M., Aggarwal D. Human aflatoxicosis in developing countries: a review of toxicology, exposure, potential health consequences, and interventions. Am. J. Clin. Nutr. 2004, 80:1106-1122.